Zdrowie i gospodarka · 06/05/2022

FDA Classifies Reverse Central Venous Recanalization System as Class II Device with Special Controls

The FDA has classified the reverse central venous recanalization system as a Class II device with special controls, aiming to ensure its safety and effectiveness while expanding patient access to innovative devices.